Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.2886 -0.0390 (-11.90%)
Delayed Quote Updated: 2:43 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months
Via ACCESSWIRE
News headline image
Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE
Via ACCESSWIRE
News headline image
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains
Via ACCESSWIRE
News headline image
Why Cosmos Health Stock Is Trading Higher Friday ↗
On Thursday afternoon, the global healthcare company announced it had signed an exclusive distribution agreement with Pharmalink for 130,000 units of its Sky Premium Life products in the United Arab... 
Via Benzinga
News headline image
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today? ↗
Elicio Therapeutics stock is down on Friday after the company announced a proposed public offering for shares of ELTX this morning. 
Via InvestorPlace
News headline image
Why Is Nexalin Technology (NXL) Stock Down 35% Today? ↗
Nexalin Technology stock is down on Friday after the company announced the pricing of NXL shares in the public offering. 
Via InvestorPlace
News headline image
Why Is Cosmos Health (COSM) Stock Up 65% Today? ↗
Cosmos Health stock is up on Friday with heavy trading of COSM shares following news of a distribution agreement in the UAE. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower! 
Via InvestorPlace
News headline image
Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units
Via ACCESSWIRE
News headline image
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent
Via ACCESSWIRE
News headline image
Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q
Via ACCESSWIRE
News headline image
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
Via ACCESSWIRE
News headline image
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks ↗
These are the list of healthcare stocks to avoid that present challenges indicating signs of a crash in the near future. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Via ACCESSWIRE
News headline image
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
Via ACCESSWIRE
News headline image
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
Via ACCESSWIRE
News headline image
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
Via ACCESSWIRE
News headline image
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
Via ACCESSWIRE
News headline image
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying ↗
The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
Via ACCESSWIRE
News headline image
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
Via ACCESSWIRE
News headline image
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
Via ACCESSWIRE
News headline image
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
Via ACCESSWIRE
News headline image
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
Via ACCESSWIRE
News headline image
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.